Megagly 4mg (Glimepiride)

Adult dose

1. Monotherapy - Initial dose: 1 mg of glimepiride once daily - Increase by 1 mg every 1-2 weeks if necessary - Generally maximum dose is 4 mg, can increase to 6 mg or 8 mg in certain cases - Consider insulin therapy or combination therapy if 4 mg daily fails - Take without chewing, with more than 1/2 cup of water - Administer orally once daily with breakfast

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Patients with allergies to this drug or its ingredients, as well as to sulfonylureas or sulfonamide drugs, should also not take this medication. There is no experience with its use in patients with severe impairment of liver or kidney function, and it is recommended to switch to insulin therapy in such cases. Women who are pregnant or may become pregnant, as well as those who are breastfeeding, should not take this medication. Patients with severe infections, or those undergoing surgery or severe trauma, should also receive insulin therapy. Care should be taken in cases of gastrointestinal disorders, such as diarrhea or vomiting, as food absorption may not be adequate, leading to hypoglycemia. This medication contains lactose, so it should not be taken by patients with lactose intolerance or specific genetic metabolic disorders. During the first week of treatment, there is a high risk of hypoglycemia, so careful monitoring is required. Patients who are malnourished or skip meals, as well as those with irregular eating habits, are at a greater risk of hypoglycemia. Caution should also be exercised when there is an imbalance between exercise and carbohydrate intake or if meal patterns change. Those who frequently consume alcohol or particularly skip meals are at a higher risk of hypoglycemia and should be more vigilant. Hypoglycemia can easily occur in patients with decreased kidney or liver function or in cases of overdose with this medication. Additionally, endocrine disorders such as thyroid dysfunction, pituitary dysfunction, or adrenal insufficiency can influence blood sugar control. Elderly patients or those taking other medications also have an increased risk of hypoglycemia and should be managed carefully with consultation from a doctor. This medication can cause hypoglycemia due to its blood sugar-lowering effect. Symptoms of hypoglycemia can include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, loss of consciousness, etc. Blurred vision, gastrointestinal disorders, abdominal pain, and diarrhea may also occur. Changes in liver function, alterations in blood cell counts, and allergic reactions can occur rarely, so any abnormal symptoms should be reported to healthcare personnel immediately. Severe hypoglycemia or allergic reactions can be life-threatening, requiring urgent treatment. This medication should be taken regularly, and optimal blood sugar control is possible when combined with dietary and exercise therapy. If hypoglycemia occurs, quick intake of sugar is necessary to relieve symptoms, and it is advisable to always carry sugary drinks or foods. During the initial treatment period, hypoglycemic symptoms should be closely monitored, and consultation with a doctor should occur in the event of other illnesses or lifestyle changes. Special caution is required when operating vehicles or machinery while taking this medication. This medication can interact with other drugs; therefore, if other medications are being taken, it is essential to inform the healthcare provider. Particularly, concurrent use with certain antibiotics, antifungals, antihypertensives, anticoagulants, and beta-blockers can affect blood sugar control. Beta-blockers and similar drugs may mask some symptoms of hypoglycemia, so additional caution is warranted. It is safe for pregnant or breastfeeding women to avoid this medication, and insulin therapy may be recommended if necessary. Particularly for breastfeeding women, care should be taken to prevent the baby from ingesting the medication. Safety and efficacy in children under 18 years of age have not been established, so use is not recommended. Elderly patients may have decreased kidney function, so the dosage of this medication should be adjusted carefully. In the event of an overdose of this medication, hypoglycemia may occur, requiring immediate emergency treatment. Inducing vomiting or administering activated charcoal and laxatives may be necessary, and in severe cases, intravenous glucose should be administered to maintain normal blood sugar levels.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, low blood pressure, shock, skin mucous membrane syndrome (Stevens-Johnson syndrome), anaphylaxis, angioedema, liver function failure, jaundice, cerebral convulsions, loss of consciousness, coma, and thrombocytopenia with platelet counts below 10,000/μL and thrombocytopenic purpura.

Mild side effects

• Headache
• severe hunger
• nausea
• vomiting
• fatigue
• sleep disturbances
• anxiety
• aggression
• decreased concentration
• decreased agility or activity

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the medication's effectiveness and safety.

Appearance

Light blue oblong tablets

Package unit

30 tablets/bottle, 100 tablets/bottle